BIO.News Newsletter

We recap what biopharma CEOs said on Capitol Hill yesterday, and the launch of a new cloud-based platform that would streamline information and data exchange between drug developers and regulators worldwide. (698 words, 3 minutes, 29 seconds)

BIO Board member Eddie J. Sullivan testified on the Hill yesterday about the impact an expanded IP waiver would have on innovative biotechs like SAb Biotherapeutics—we have a recap, as well as yesterday’s House vote to prohibit the use of QALYs in federal programs. (532 words, 2 minutes, 39 seconds)

A busy day on Capitol Hill advances legislation on PBMs and preventive care, and brings important discussions on antimicrobial resistance. Meanwhile, BIO tells the Biden administration why Bayh-Dole cannot be used for drug price controls. (587 words, 2 minutes, 56 seconds)

Americans want climate solutions, finds Yale research. Meanwhile, flu is on the rise, and not enough Americans are vaccinated. (546 words, 2 minutes, 43 seconds)

BIO warns USTR of global threats to U.S. IP (including WTO waivers), while several new reports highlight the importance of biotech to sustainable farm productivity. (621 words, 3 minutes, 6 seconds)

We recap a busy week, with activity on drug price controls and a look at alarming surges in measles around the world. (484 words, 2 minutes, 25 seconds)

What a day on Capitol Hill. Yesterday brought the introduction of a bill that would fix the small molecule “pill penalty” in the Inflation Reduction Act, the passage of legislation to restore immediate R&D expensing, and a discussion on the need for PBM reform—we recap everything below. (766 words, 3 minutes, 49 seconds)

The House readies for a possible vote on restoring immediate R&D expensing, and BIO’s Phyllis Arthur says the next health crisis—antimicrobial resistance—is already here. (576 words, 2 minutes, 52 seconds)

We could eliminate cervical cancer—with widespread HPV vaccination. We have details on a promising new study, plus a panel discussion last week at UCLA about the growing problem of antimicrobial resistance. (646 words, 3 minutes, 13 seconds)

Beginning a new week with a look at BIO’s congressional priorities for 2024—and how you can take action on some of them—as well as progress on Biden’s bioeconomy executive order. (544 words, 2 minutes, 43 seconds)